GlassScriptPhysician profile
Robert W Donnell
NPI 1306803655
$536.07
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.28 · 2020: $33.97 · 2021: $65.24 · 2022: $29.28 · 2023: $93.20 · 2024: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $135.39 | 2022-2024 | |
| Abiomed | $92.99 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $86.94 | 2020-2024 | Xarelto |
| Ironshore Pharmaceuticals INC. | $54.42 | 2024 | |
| Pfizer INC. | $51.54 | 2019-2021 | |
| Abbvie INC. | $45.08 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.95 | 2024 | Jardiance |
| Vapotherm INC | $23.19 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Donnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.